Fund Holdings — Sanofi

Total Portfolio Value:
$310.41M
Total Bought:
$16.02M
Total Sold:
$14.60M
Net Transaction:
+$1.42M
Securities
▲▼
SharesValue
Q3 2025
▲▼
Q4 2025
▲▼
Change
▲▼
Q3 2025
▲▼
Q4 2025
▲▼
Weight (%)
▲▼
Change
▲▼
MeiraGTx Holdings plc(MGTX)12,197,73712,197,7370$100.39M$96.97M31.24%-$3.42M
Inhibrx Biosciences, Inc.(INBX)1,157,9261,157,9260$39.00M$91.48M29.47%+$52.48M
Novavax, Inc.(NVAX)6,880,4816,880,4810$59.65M$46.24M14.90%-$13.42M
AnaptysBio821,917821,9170$25.17M$39.85M12.84%+$14.68M
Immuneering CorpCL A2,708,5592,708,5590$18.96M$17.82M5.74%-$1.14M
MapLight Therapeutics, Inc.(MPLT)0912,041+912,041$0$16.02M5.16%+$16.02M
Eledon Pharmaceuticals, Inc.(ELDN)814,980814,9800$2.11M$1.23M0.40%-$880.2K
Q32 Bio Inc.(QTTB)244,083244,0830$483.3K$810.4K0.26%+$327.1K
LAVA Therapeutics N.V.SHS1,919,4550-1,919,455$2.99M$0—-$2.99M
Omada Health, Inc.(OMDA)524,9030-524,903$11.61M$0—-$11.61M
Page 1 of 1
Sanofi — 13F Holdings — Q4 2025 | TickerTrail